N/A
Completed N=134
Remifentanil in Deep vs Moderate Neuromuscular Blocks During Surgical Pleth Index-guided Anesthesia for Laparoscopic Herniorrhaphy
Hernia Abdominal Wall
Source: ClinicalTrials.gov NCT04022733 ↗
Enrolled (actual)
134
Serious AEs
0.0%
Results posted
Mar 2022
Primary outcomePrimary: Remifentanil Infusion Rate — 0.103; 0.073 µg/kg/min
Summary
The primary purpose of this study is to compare the remifentanil requirements in deep versus moderate neuromuscular blocks during the surgical pleth index -guided anesthesia in patients undergoing laparoscopic herniorrhaphy.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Remifentanil Infusion Rate |
0.103; 0.073 | — |
Eligibility Criteria
Inclusion Criteria
- laparoscopic hernia repair
Exclusion Criteria
- patients refusal, hyperbilirubinemia, chronic pain, opioid abuse, infection, and peripheral disease
Data sourced from ClinicalTrials.gov (NCT04022733). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.